InternationalUSRemember you can easily switch between MIP US and MIP International at any time

What now for compulsory licences?

Emma Barraclough, London

Today India has granted its first compulsory licence over a drug. But what of other countries that have used the IP system to make it easier for patients to access medicines?


Six years ago the government of Thailand took a decision that sent research pharmaceutical companies into a panic: it issued a compulsory licence for Merck’s antiretroviral drug efavirenz.

The product is marketed by Bristol-Myers Squibb in the US...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

Latest Country Updates


Most read articles